Anna Berkenblit Immuno Gen, Inc. (IMGN) insider trading activity

IMGN Quotes by TradingView

Anna Berkenblit is SVP & CHIEF MEDICAL OFFICER of ImmunoGen, Inc.. Currently has a direct ownership of 113,935 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2023, when has been sold 3,264 shares (Common Stock) at a price of $4.05 per share, resulting in proceeds of $13,219. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
0% 3M change
0% 12M change
Total Value Held $0

Anna Berkenblit Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2023
BUY
Grant, award, or other acquisition
$13,219 $4.05 p/Share
3,264 Added 2.79%
113,935 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$1,709 $3.92 p/Share
436 Added 0.39%
110,671 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$11,770 $3.83 p/Share
3,073 Added 2.71%
110,235 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$9,862 $5.6 p/Share
1,761 Added 1.62%
107,162 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$11,382 $5.52 p/Share
2,062 Added 1.92%
105,401 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$8,900 $4.04 p/Share
2,203 Added 2.09%
103,339 Common Stock

Also insider at

SRZN
Surrozen, Inc. Healthcare
AB

Anna Berkenblit

SVP & CHIEF MEDICAL OFFICER
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMGN